Cargando…

HIV-1 Nef interacts with the cyclin K/CDK13 complex to antagonize SERINC5 for optimal viral infectivity

HIV-1-negative factor (Nef) protein antagonizes serine incorporator 5 (SERINC5) by redirecting this potent restriction factor to the endosomes and lysosomes for degradation. However, the precise mechanism remains unclear. Using affinity purification/mass spectrometry, we identify cyclin K (CycK) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Qingqing, Li, Sunan, Collins, Morgan K., Li, Rongrong, Ahmad, Iqbal, Johnson, Silas F., Frabutt, Dylan A., Yang, Zhichang, Shen, Xiaojing, Sun, Liangliang, Hu, Jian, Hultquist, Judd F., Peterlin, B. Matija, Zheng, Yong-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385645/ https://www.ncbi.nlm.nih.gov/pubmed/34380030 http://dx.doi.org/10.1016/j.celrep.2021.109514

Ejemplares similares

Cul3-KLHL20 E3 ubiquitin ligase plays a key role in the arms race between HIV-1 Nef and host SERINC5 restriction
por: Li, Sunan, et al.
Publicado: (2022)

Proteasomal degradation of human SERINC4: A potent host anti-HIV-1 factor that is antagonized by nef
por: Qiu, Xusheng, et al.
Publicado: (2020)

Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor
por: Fackler, Oliver T.
Publicado: (2015)

Nef Obtained from Individuals with HIV-1 Vary in Their Ability to Antagonize SERINC3- and SERINC5-Mediated HIV-1 Restriction
por: Kruize, Zita, et al.
Publicado: (2021)

Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5
por: Jin, Steven W., et al.
Publicado: (2020)

SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
por: Usami, Yoshiko, et al.
Publicado: (2015)

Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5
por: Wu, Yuanfei, et al.
Publicado: (2019)

Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity
por: Jin, Steven W., et al.
Publicado: (2019)

HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity
por: Naicker, Delon, et al.
Publicado: (2023)

Nef enhances HIV-1 replication and infectivity independently of SERINC5 in CEM T cells
por: Ramirez, Peter W., et al.
Publicado: (2023)

Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals
por: Toyoda, Mako, et al.
Publicado: (2020)

AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4
por: Olety, Balaji, et al.
Publicado: (2023)

Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study
por: Sudderuddin, Hanwei, et al.
Publicado: (2020)

A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation
por: Firrito, Claudia, et al.
Publicado: (2023)

A Truncated Nef Peptide from SIVcpz Inhibits the Production of HIV-1 Infectious Progeny
por: Sabino Cunha, Marcela, et al.
Publicado: (2016)

Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1
por: Costa, Luciana J, et al.
Publicado: (2006)

HIV-1 restriction by SERINC5
por: Cano-Ortiz, Lucía, et al.
Publicado: (2022)

Tetherin/BST-2 Antagonism by Nef Depends on a Direct Physical Interaction between Nef and Tetherin, and on Clathrin-mediated Endocytosis
por: Serra-Moreno, Ruth, et al.
Publicado: (2013)

Novel monoclonal antibodies to the SERINC5 HIV-1 restriction factor detect endogenous and virion-associated SERINC5
por: Molnar, Sebastian, et al.
Publicado: (2020)

SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue
por: Kmiec, Dorota, et al.
Publicado: (2018)

Cyclin K goes with Cdk12 and Cdk13
por: Kohoutek, Jiri, et al.
Publicado: (2012)

SERINC5 restricts influenza virus infectivity
por: Zhao, Fei, et al.
Publicado: (2022)

Restriction of Influenza A Virus by SERINC5
por: Lai, Kin Kui, et al.
Publicado: (2022)

Molecular docking analysis of piperine with CDK2,CDK4,Cyclin D and Cyclin T proteins
por: Rekha, Umapathy Vidhya, et al.
Publicado: (2020)

HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef
por: Sauter, Daniel, et al.
Publicado: (2011)

SERINC5 Potently Restricts Retrovirus Infection In Vivo
por: Timilsina, Uddhav, et al.
Publicado: (2020)

Nuclear Import of Cdk/Cyclin Complexes: Identification of Distinct Mechanisms for Import of Cdk2/Cyclin E and Cdc2/Cyclin B1
por: Moore, Jonathan D., et al.
Publicado: (1999)

Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2
por: Zhang, Wengang, et al.
Publicado: (2023)

SIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release
por: Zhang, Fengwen, et al.
Publicado: (2011)

Loss of tetherin antagonism by Nef impairs SIV replication during acute infection of rhesus macaques
por: Tavakoli-Tameh, Aidin, et al.
Publicado: (2020)

SERINC5: One antiviral factor to bind them all
por: Timilsina, Uddhav, et al.
Publicado: (2023)

Antiviral Role of Serine Incorporator 5 (SERINC5) Proteins in Classical Swine Fever Virus Infection
por: Li, Wenhui, et al.
Publicado: (2020)

Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
por: Matsumoto, M, et al.
Publicado: (1999)

Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef
por: Matheson, Nicholas J., et al.
Publicado: (2015)

Cyclin B/CDK1 and Cyclin A/CDK2 phosphorylate DENR to promote mitotic protein translation and faithful cell division
por: Clemm von Hohenberg, Katharina, et al.
Publicado: (2022)

SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV
por: Gonzalez-Enriquez, Gracia Viviana, et al.
Publicado: (2017)

SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma
por: Zeng, Yuan, et al.
Publicado: (2018)

Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor
por: Passos, Vânia, et al.
Publicado: (2019)

Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity
por: Diehl, William E., et al.
Publicado: (2021)

HIV envelope tail truncation confers resistance to SERINC5 restriction
por: Haider, Tafhima, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t0dg0vg7a7ignpq0jiefkgn3kl